Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Michaux

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2013
Identifying source proteins for MHC class I-presented peptidesNathalie Vigneron, Wenbin Ma, Alexandre Michaux, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 1, 2019
Identifying Antigens Recognized by Cytolytic T Lymphocytes on TumorsNathalie Vigneron, Vincent Stroobant, Wenbin Ma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2014
A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimmingAlexandre Michaux, Pierre Larrieu, Vincent Stroobant, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 22, 2022
Clinical Grade Manufacture of CYAD-101, a NKG2D-based, First in Class, Non-Gene-edited Allogeneic CAR T-Cell TherapyAlexandre Michaux, Sébastien Mauën, Eytan Breman, et al.
European Journal of Immunology|June 9, 2012
Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be improved by acid treatment or fixation of target cellsVincent Stroobant, Nathalie Demotte, Rosalie M Luiten, et al.
Frontiers in Immunology|January 9, 2019
Overcoming Target Driven Fratricide for T Cell TherapyEytan Breman, Benjamin Demoulin, Sophie Agaugué, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2013
Identifying source proteins for MHC class I-presented peptidesNathalie Vigneron, Wenbin Ma, Alexandre Michaux, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 1, 2019
Identifying Antigens Recognized by Cytolytic T Lymphocytes on TumorsNathalie Vigneron, Vincent Stroobant, Wenbin Ma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2014
A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimmingAlexandre Michaux, Pierre Larrieu, Vincent Stroobant, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 22, 2022
Clinical Grade Manufacture of CYAD-101, a NKG2D-based, First in Class, Non-Gene-edited Allogeneic CAR T-Cell TherapyAlexandre Michaux, Sébastien Mauën, Eytan Breman, et al.
European Journal of Immunology|June 9, 2012
Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be improved by acid treatment or fixation of target cellsVincent Stroobant, Nathalie Demotte, Rosalie M Luiten, et al.
Frontiers in Immunology|January 9, 2019
Overcoming Target Driven Fratricide for T Cell TherapyEytan Breman, Benjamin Demoulin, Sophie Agaugué, et al.
Pageof 1